Literature DB >> 1821611

Synthesis and expression in E. coli of the gene for human tumor necrosis factor (h alpha TNF).

J Kłysik1, A Konarzewska-Zglińska, G Gałazka, B Uznański, A Okruszek, P Guga, A Wilk, M Koziołkiewicz, H Tchórzewski, M Zembala.   

Abstract

A gene coding for human tumor necrosis factor (h alpha TNF) has been assembled by ligating short oligodeoxyribonucleotides and cloning into plasmid vectors. These oligonucleotides were prepared by the modified phosphoramidite methodology using isopropoxyacetyl (IPA) as a protecting group for exoamino- functions of nucleosides. Gene was expressed in E. coli and the protein product was purified to homogeneity by ion-exchange chromatography.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1821611

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  3 in total

1.  The effect of tumour necrosis factor-alpha (TNF-alpha) muteins on human neutrophils in vitro.

Authors:  H Tchorzewski; K Zeman; J Kantorski; E Paleolog; M Kahan; M Feldmann; M Kwinkowski; P Guga; B Szymanska; P Parniewski; A Wilk; J Jarosz
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

2.  The influence of 2- chlorodeoxyadenosine in combination with tumour necrosis factor-alpha or its mutein on murine leukaemias L1210 and P388.

Authors:  J Góra-Tybor; K Warzocha; T Robak
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

3.  A comparison of the Antileukaemic Effects of Recombinant Human Tumour Necrosis Factor-alpha and its Muteins on Leukaemia L1210 and Leukaemia P388 in Mice.

Authors:  K Warzocha; J Góra-Tybor; M Kwinkowski; B Szymańska; T Robak
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.